GH Research Quarterly Balance Sheet
NASDAQ: GHRSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
GH Research financial position
As of Dec 31, 2025, GH Research reported total assets of $288.2 million, up 3.0% from a year earlier against total liabilities of $8.5 million. Shareholders' equity stood at $279.7 million, or 97.0% of assets. The company held $246.3 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 34.13, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
GH Research balance sheet (quarterly)
| Quarter (USD) | Q4 20252025-12-31 | Q4 20242024-12-31 | Q4 20232023-12-31 | Q4 20222022-12-31 | Q4 20212021-12-31 | Q4 20202020-12-31 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 246.25M | 100.79M | 78.42M | 165.96M | 276.78M | 5.89M |
| Total Current Assets | 285.98M | 154.22M | 164.09M | 168.54M | 279.84M | 5.91M |
| Property, Plant & Equipment | 620.00K | 748.00K | 1.07M | 97.00K | 82.00K | 0 |
| Total Assets | 288.23M | 188.27M | 226.30M | 254.36M | 279.92M | 5.91M |
| Accounts Payable | 3.77M | 3.74M | 3.49M | 1.87M | 883.00K | 1.00K |
| Total Current Liabilities | 8.38M | 8.95M | 6.70M | 4.55M | 2.75M | 246.00K |
| Total Liabilities | 8.53M | 9.32M | 7.33M | 4.55M | 2.75M | 246.00K |
| Shareholders' Equity | 279.70M | 178.95M | 218.97M | 249.82M | 277.18M | 5.67M |
| Retained Earnings | -154.43M | -106.45M | -67.94M | -32.49M | -10.04M | -835.00K |
| Net Cash (Debt) | 246.25M | 100.79M | 78.42M | 165.96M | 276.78M | 5.89M |
This table shows 6 quarterly periods of GH Research's balance sheet, from Q4 2025 back to Q4 2020, across 10 line items including cash & equivalents, total current assets, property, plant & equipment. Values in USD; B = billions, M = millions. Fiscal periods follow GHRS's reporting calendar. What is a balance sheet?